Your browser doesn't support javascript.
loading
Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry.
Kagina, Benjamin M; Mansoor, Nazma; Kpamegan, Eloi P; Penn-Nicholson, Adam; Nemes, Elisa; Smit, Erica; Gelderbloem, Sebastian; Soares, Andreia P; Abel, Brian; Keyser, Alana; Sidibana, Mzwandile; Hughes, Jane E; Kaplan, Gilla; Hussey, Gregory D; Hanekom, Willem A; Scriba, Thomas J.
Afiliación
  • Kagina BM; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa; Vaccines for Africa Initiative, Division of Medical Microbiology & Institute of Infectious Disease and M
  • Mansoor N; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa; BD Biosciences, Johannesburg, South Africa.
  • Kpamegan EP; Aeras, Rockville, MD, USA.
  • Penn-Nicholson A; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa.
  • Nemes E; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa.
  • Smit E; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa.
  • Gelderbloem S; Aeras, Cape Town, South Africa.
  • Soares AP; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa; Division of Medical Virology, Institute of Infectious Disease and Molecular Medicine, University of Cape Tow
  • Abel B; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore.
  • Keyser A; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa.
  • Sidibana M; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa.
  • Hughes JE; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa.
  • Kaplan G; Public Health Research Institute, NJMS Rutgers, Newark, NJ, USA; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Hussey GD; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa; Vaccines for Africa Initiative, Division of Medical Microbiology & Institute of Infectious Disease and M
  • Hanekom WA; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa.
  • Scriba TJ; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa. Electronic address: thomas.scriba@uct.ac.za.
J Immunol Methods ; 417: 22-33, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25523923

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Vacuna BCG / Linfocitos T CD4-Positivos / Citocinas / Linfocitos T CD8-positivos / Mycobacterium bovis Tipo de estudio: Diagnostic_studies Límite: Adult / Humans Idioma: En Revista: J Immunol Methods Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Vacuna BCG / Linfocitos T CD4-Positivos / Citocinas / Linfocitos T CD8-positivos / Mycobacterium bovis Tipo de estudio: Diagnostic_studies Límite: Adult / Humans Idioma: En Revista: J Immunol Methods Año: 2015 Tipo del documento: Article